Horizon Discovery

Horizon Discovery is a Cambridge-based life sciences company supplying gene editing and gene modulation tools, services, and engineered cell lines to pharmaceutical, biotechnology, and academic customers.

Its portfolio includes CRISPR and RNAi reagents, isogenic cell line pairs modelling disease-associated mutations, RNA synthesis, functional genomic screening services, and molecular reference standards for NGS-based diagnostics.

The Cambridge site operates as a centre of excellence for genomic research within parent company Revvity.